McGill Newsroom

Extensive population-based studies on a popular group of drugs used to treat type 2 diabetes revealed no association with acute pancreatitis, but increased risk of bile duct and gallbladder disease

Classified as: Biostatistics, hypoglycemia, Laurent Azoulay, diabetes, occupational health, Department of Epidemiology, type 2, Lady Davis Institute at the Jewish General Hospital, Gerald Bronfman Department of Oncology, incretin-based drugs
Published on: 1 Aug 2016

McGill Newsroom

Study reveals the impact of night work

You cross paths with him at the break of dawn in the corridors of the Metro. He looks bleary-eyed and pallid. This worker’s night shift just ended. His body clocks are out of sync with one another, and, imperceptibly, they’re also out of sync with his environment. In the long run, this night owl could be at greater risk of developing cardiovascular, autoimmune diseases or certain types of cancer.

Classified as: Cancer, immune system, Douglas Mental Health University Institute, shift workers, body clock, internal clock, clock, Marc Cuesta, Nicolas Cermakian, Diane B. Biovin, Journal of Immunology
Published on: 14 Jun 2016

McGill Newsroom

Newly named Gerald Bronfman Department of Oncology recognizes family’s enduring support

In recognition of the Bronfman family’s enduring support for oncology programs and research at McGill University, the Faculty of Medicine’s Department of Oncology has been named the Gerald Bronfman Department of Oncology, in honour of one of the family’s major benefactors.

Classified as: Cancer, Oncology, Gerald Bronfman, Bronfman family
Published on: 13 Jun 2016

McGill Newsroom

Antibiotic resistance represents a major challenge in treating pathogenic bacterial infections.

Now, researchers at McGill University have discovered a possible target for fighting back against resistant bacteria.

Classified as: antibiotics, Antibiotic resistance, health and lifestyle, bacterial infection, Albert Berghuis, enzyme, motion sensors, pathogenic bacteria
Published on: 9 Jun 2016

McGill Newsroom

Pioneering research at McGill’s Goodman Cancer Research Centre gets boost

The 4th Goodman Cancer Research Gala has raised more than $2.1 million to fund foundational research, more effective diagnostic tools and the development of new treatments and therapies for cancer patients.  The Gala was held on Sunday, June 5 in Montreal, bringing together more than 800 guests in support of McGill University’s Rosalind and Morris Goodman Cancer Research Centre.

Classified as: treatment, faculty of medicine, Nahum Sonenberg, Cancer, Goodman Cancer Research Centre, research centre, health and lifestyle, pioneering, Rosalind Goodman, Ian Watson, Nicole Beauchemin
Published on: 6 Jun 2016

Raising awareness about stroke

 

Every ten minutes, someone in Canada suffers a stroke. Strokes kill 14,000 Canadians each year, making stroke the third leading cause of death in this country.

The Montreal Neurological Institute and Hospital (The Neuro) hopes to increase public awareness about the dangers of stroke by marking Stroke Month. People who learn about the causes of stroke can take measures to reduce their chances of having a stroke.

 

What is a stroke?

 

Classified as: stroke, stroke month, Montreal Neurological Institute, Maria Del Pilar Cortes Nino, Jeanne Teitelbaum
Published on: 6 Jun 2016

Neurofeedback using electroencephalograpy boasts thousands of practitioners and appears to both improve normal brain function and alleviate a wide variety of mental disorders – from anxiety to alcoholism. But after examining the scientific literature and consulting experts in Europe and the U.S., McGill University researchers Robert Thibault and Amir Raz conclude that clinical improvements from this increasingly popular alternative therapy are due to placebo effects.

Classified as: Psychiatry, health and lifestyle, neuroproject, neuroprojects, neurofeedback, electroencephalograpy, placebo effects, psychological influences, social influences
Published on: 2 Jun 2016

McGill Newsroom

McGill alumnus tagged to boost capacity and discovery in growing field

Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced as the inaugural Albert Boehringer (1st) Chair in Pharmacoepidemiology during an event held May 26 at McGill.

Classified as: Pharmacology, epidemiology, Pharmacoepidemiology, health and lifestyle, growing, Albert Boehringer, David Eidelman
Published on: 27 May 2016

McGill Newsroom

Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing antidepressants for nondepressive indications, including unapproved (off-label) indications that have not been evaluated by regulatory agencies.

Classified as: depression, pain, health and lifestyle, antidepressant, Jenna Wong, manoamine oxidase inhibitors, insomnia, panic disorders
Published on: 24 May 2016

By Shawn Hayward, Montreal Neurological Institute and Hospital

Discovery will aid development of treatments for this debilitating disease

Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.

Classified as: Guy Rouleau, MNI, Montreal Neurological Institute and Hospital, HSP, hereditary spastic paraplegia, gene mutation, debilitating disease, weakness, spasticity, CanHSP, Canadian Institutes for Health Research
Published on: 10 May 2016

McGill Newsroom

Discovery offers hope for more effective treatments of deadly glioblastomas

A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.

Classified as: neuroscience, brain, Lady Davis Institute, science and technology, tumor, glioblastoma, tumour, Jahani-Asl, OSMR, neuroproject
Published on: 25 Apr 2016

McGill Newsroom

CREATE project to prepare graduates for high-skills work in surgical-devices industry

A team led by McGill University professor Jake Barralet will receive $1.65 million from the Natural Sciences and Engineering Research Council of Canada to provide nearly 90 students with cross-disciplinary training to prepare them for high-skill jobs in the surgical devices industry.

Classified as: Natural Sciences and Engineering Research Council of Canada, NSERC, Collaborative Research and Training Experience, science and technology, surgical-devices industry, Jake Barralet, Greg Fergus, Science and Economic Development, Rosie Goldstein
Published on: 14 Apr 2016

Pages

Back to top